Algorithms to detect early stage pancreatic cancer
PRedictiOn Algorithms for the DeTECTion of Early Stage Pancreatic Cancer (PRO-TECT)
This study is working on new ways to spot pancreatic cancer earlier by using smart computer tools to look at patient information and images, so that people at high risk can get the care they need sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-10656240 on NIH RePORTER |
What this research studies
This research aims to improve the early detection of pancreatic cancer, which is often diagnosed at a late stage due to a lack of effective screening methods. The project will develop algorithms that analyze patient data and imaging results to identify individuals at high risk for developing pancreatic cancer. By utilizing advanced data-driven techniques, including natural language processing, the research seeks to enhance the accuracy of early diagnosis and facilitate timely treatment. Patients who are identified as high-risk will be monitored more closely, potentially leading to earlier interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at high risk for pancreatic cancer, including those with specific genetic predispositions or existing health conditions.
Not a fit: Patients with no risk factors for pancreatic cancer or those already diagnosed with advanced pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the early detection rates of pancreatic cancer, improving survival outcomes for patients.
How similar studies have performed: Previous research has shown promise in using algorithm-based approaches for cancer detection, indicating that this methodology could be effective for pancreatic cancer as well.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Wu, Bechien — Kaiser Foundation Research Institute
- Study coordinator: Wu, Bechien
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.